TREATMENT OF THE ALCOHOLIC ORGANIC BRAIN-SYNDROME - DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL, PSYCHOMETRIC AND ELECTROENCEPHALOGRAPHIC MAPPING STUDIES WITH MODAFINIL

被引:21
作者
SALETU, B [1 ]
SALETU, M [1 ]
GRUNBERGER, J [1 ]
FREY, R [1 ]
ANDERER, P [1 ]
MADER, R [1 ]
机构
[1] ANTON PROKSCH INST, VIENNA, AUSTRIA
关键词
ALCOHOLIC ORGANIC BRAIN SYNDROME; MODAFINIL; CLINICAL INVESTIGATION; PSYCHOMETRY; PSYCHOPHYSIOLOGY; ELECTROENCEPHALOGRAPHIC MAPPING;
D O I
10.1159/000118950
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In a double-blind study 40 abstinent hospitalized male patients with an alcoholic organic brain syndrome (OBS; ICD 9: 291.2) were treated for 6 weeks with either placebo or 200 mg modafinil b.i.d. Modafinil (CRL 40476) is a vigilance-promoting, putative central alpha1-adrenergic agonist with a pharmacological profile quite different from that of amphetamine. Clinical investigations demonstrated that the spontaneous remission of the alcoholic OBS was augmented and accelerated by modafinil, which was found significant as compared with placebo by confirmatory statistics in the target variable, the Clinical Global Impression scale. The drug was well tolerated. Psychometric tests revealed significant improvement of the noopsyche after modafinil as compared with placebo, while the thymopsyche and psychophysiological measurements were not affected. Electroencephalographic mapping showed significant differences between the central effects of modafinil and placebo indicating an improvement of vigilance under modafinil. Typical vigilance-promoting properties were seen after acute drug administration, were less evident before the morning dose after chronic treatment but re-occurred after superimposed daily drug administration. Thus, our clinical, psychometric and neurophysiological investigations in alcoholic OBS patients demonstrated a therapeutic effect of modafinil in the early phase of abstinence.
引用
收藏
页码:26 / 39
页数:14
相关论文
共 55 条
  • [1] ANDERER P, 1987, METHOD FIND EXP CLIN, V9, P371
  • [2] SUCCESSFUL TREATMENT OF IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY WITH MODAFINIL
    BASTUJI, H
    JOUVET, M
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (05) : 695 - 700
  • [3] THE VALUE OF ELECTROENCEPHALOGRAPHY IN ALCOHOLISM
    BENNETT, AE
    DOI, LT
    MOWERY, GL
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1956, 124 (01) : 27 - 32
  • [4] Bente D, 1977, Verh Dtsch Ges Inn Med, V83, P945
  • [5] BERNE RP, 1977, PSYCHIATRISCHE SYSTE
  • [6] CHANGES IN DEPRESSION AMONG ABSTINENT ALCOHOLICS
    BROWN, SA
    SCHUCKIT, MA
    [J]. JOURNAL OF STUDIES ON ALCOHOL, 1988, 49 (05): : 412 - 417
  • [7] Butters N., 1980, ALCOHOLIC KORSAKOFFS
  • [8] PSYCHOSTIMULANTS, ANALEPTICS, NOOTROPICS - AN ATTEMPT TO DIFFERENTIATE AND ASSESS DRUGS DESIGNED FOR THE TREATMENT OF IMPAIRED BRAIN FUNCTIONS
    COPER, H
    HERRMANN, WM
    [J]. PHARMACOPSYCHIATRY, 1988, 21 (05) : 211 - 217
  • [9] POSITRON EMISSION TOMOGRAPHY IN ALZHEIMERS-DISEASE
    DUARA, R
    GRADY, C
    HAXBY, J
    SUNDARAM, M
    CUTLER, NR
    HESTON, L
    MOORE, A
    SCHLAGETER, N
    LARSON, S
    RAPOPORT, SI
    [J]. NEUROLOGY, 1986, 36 (07) : 879 - 887
  • [10] POSSIBLE ALPHA-ADRENERGIC MECHANISM FOR DRUG (CRL40028)-INDUCED HYPERACTIVITY
    DUTEIL, J
    RAMBERT, FA
    PESSONNIER, J
    GOMBERT, R
    ASSOUS, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 59 (1-2) : 121 - 123